Muller & Phipps (India) Limited (BOM:501477)
209.10
-10.25 (-4.67%)
At close: Aug 24, 2026
Muller & Phipps (India) Revenue
Muller & Phipps (India) had revenue of 17.90M INR in the quarter ending June 30, 2026, a decrease of -10.17%. This brings the company's revenue in the last twelve months to 67.05M, up 1.02% year-over-year. In the fiscal year ending March 31, 2026, Muller & Phipps (India) had annual revenue of 69.08M with 11.51% growth.
Revenue (ttm)
67.05M
Revenue Growth
+1.02%
P/S Ratio
1.96
Revenue / Employee
n/a
Employees
n/a
Market Cap
131.19M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 69.08M | 7.13M | 11.51% |
| Mar 31, 2025 | 61.94M | 17.65M | 39.83% |
| Mar 31, 2024 | 44.30M | 2.62M | 6.29% |
| Mar 31, 2023 | 41.68M | 2.38M | 6.04% |
| Mar 31, 2022 | 39.30M | -2.96M | -7.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.29B |
| Medico Intercontinental | 845.82M |
| Medistep Healthcare | 708.31M |
| Zenlabs Ethica | 496.22M |
| Goldline Pharmaceutical | 311.98M |
| Dhruv Wellness | 2.17M |
| Priya | 10.00K |